 |
|
|
|
|
Press Releases
|
|
 = Add Release to Briefcase |
All Releases
 |
CryoCor, Inc. Subject of Lawsuit Relating to Tender Offer and Merger
May 16, 2008
|
14.6 KB
|
|
SAN DIEGO, May 16, 2008 /PRNewswire-FirstCall via COMTEX News Network/ -- CryoCor, Inc. (Nasdaq: CRYO), a medical device company focused on the treatment of cardiac arrhythmias, announced today that on May 8, 2008, two alleged holders of CryoCor common stock filed a complaint in the Superior Court of the State of California, County of San Diego, na...
|
|
Boston Scientific and CryoCor Announce Signing of Definitive Merger Agreement
Apr 16, 2008
|
14.3 KB
|
|
NATICK, Mass. and SAN DIEGO, Calif., April 16, 2008 /PRNewswire-FirstCall via COMTEX News Network/ -- Boston Scientific Corporation (NYSE: BSX) and CryoCor, Inc. (Nasdaq: CRYO) today announced the signing of a definitive merger agreement, under which Boston Scientific will pay a cash purchase price of $1.35 per share of CryoCor, or approximately $1...
|
|
CryoCor Reports Going Concern Statement and Receives Notification From Nasdaq Relating to Minimum Stockholders' Equity
Mar 27, 2008
|
13.8 KB
|
|
SAN DIEGO, March 27, 2008 /PRNewswire-FirstCall via COMTEX News Network/ -- CryoCor, Inc. (Nasdaq: CRYO), reported today that its Annual Report on Form 10-K included an audit opinion with a "going concern" qualification. The going-concern qualification is a statement from CryoCor's independent registered public accounting firm expressing substantia...
|
|
CryoCor Reports 2007 Results
Mar 20, 2008
|
19.8 KB
|
|
SAN DIEGO, March 20, 2008 /PRNewswire-FirstCall via COMTEX News Network/ -- CryoCor, Inc. (Nasdaq: CRYO), a medical device company focused on the treatment of cardiac arrhythmias, today reported on its financial results for the year ended December 31, 2007. CryoCor reported a net loss of $15.8 million, or ($1.31) per share, for the year ended Decem...
|
|
CryoCor Announces Web cast and Conference Call of 2007 Year End Results
Mar 14, 2008
|
12.3 KB
|
|
SAN DIEGO, March 14, 2008 /PRNewswire-FirstCall via COMTEX News Network/ -- CryoCor, Inc. (Nasdaq: CRYO), a medical device company focused on the treatment of cardiac arrhythmias, announced today that it will release its financial results for the year ended December 31, 2007 on Thursday, March 20, 2008 after the close of the U.S. financial markets....
|
|
CryoCor Atrial Fibrillation Study Published in the Journal of the American College of Cardiology
Mar 10, 2008
|
14.7 KB
|
|
SAN DIEGO, March 10, 2008 /PRNewswire-FirstCall via COMTEX News Network/ -- CryoCor, Inc. (Nasdaq: CRYO), a medical device company focused on the treatment of cardiac arrhythmias, announced today the publication of a study on the treatment of atrial fibrillation utilizing the Company's Cryoablation System. The study was published in the February 26...
|
|
CryoCor Requests International Trade Commission Investigation Into CryoCath for Patent Infringement
Feb 28, 2008
|
13.9 KB
|
|
SAN DIEGO, Feb 28, 2008 /PRNewswire-FirstCall via COMTEX News Network/ -- CryoCor, Inc. (Nasdaq: CRYO), a medical device company focused on the treatment of cardiac arrhythmias, announced today that it has filed a formal complaint with the United States International Trade Commission (ITC) alleging that CryoCath Technologies Inc. has engaged in unf...
|
|
CryoCor to Present at Roth Capital Partners 20th Annual OC Growth Stock Conference
Feb 15, 2008
|
12.3 KB
|
|
SAN DIEGO, Feb 15, 2008 /PRNewswire-FirstCall via COMTEX News Network/ -- CryoCor, Inc. (Nasdaq: CRYO), a medical device company focused on the treatment of cardiac arrhythmias, announced today that Gregory J. Tibbitts, Chief Financial Officer, is scheduled to present at the Roth Capital Partners 20th Annual OC Growth Stock Conference in Dana Point...
|
|
United States Patent Office Grants CryoCor's Request for Patent Interference
Feb 13, 2008
|
13.8 KB
|
|
SAN DIEGO, Feb 13, 2008 /PRNewswire-FirstCall via COMTEX News Network/ -- CryoCor, Inc. (Nasdaq: CRYO), a medical device company focused on the treatment of cardiac arrhythmias, announced today that the United States Patent and Trademark Office (USPTO) has declared a patent interference between a patent application exclusively licensed by CryoCor a...
|
|
Dr. Warren Jackman Joins CryoCor Scientific Advisory Board
Feb 4, 2008
|
13.8 KB
|
|
SAN DIEGO, Feb 04, 2008 /PRNewswire-FirstCall via COMTEX News Network/ -- CryoCor, Inc. (Nasdaq: CRYO), a medical device company focused on the treatment of cardiac arrhythmias, announced today Warren Jackman, M.D., joined the Company's Scientific Advisory Board.
"We are extremely excited to welcome Dr. Jackman to our Scientific Advisory Board,...
|
|
CryoCor Files Patent Infringement Lawsuits Against CryoCath
Jan 16, 2008
|
7.9 KB
|
|
SAN DIEGO, Jan 16, 2008 /PRNewswire-FirstCall via COMTEX News Network/ -- CryoCor, Inc. (Nasdaq: CRYO), a medical device company focused on the treatment of cardiac arrhythmias, announced today that it filed two patent infringement lawsuits against CryoCath Technologies Inc., one in the United States District Court for the District of Delaware and ...
|
|
CryoCor to Highlight Products at 13th Annual International Boston Atrial Fibrillation Symposium
Jan 15, 2008
|
13.9 KB
|
|
SAN DIEGO, Jan 15, 2008 /PRNewswire-FirstCall via COMTEX News Network/ -- CryoCor, Inc. (Nasdaq: CRYO), a medical device company focused on the treatment of cardiac arrhythmias, announced today that it will showcase its Cardiac Cryoablation System and its next generation ablation catheter, Quantum, at the Boston Atrial Fibrillation Symposium, Janua...
|
|
CryoCor Reports Publication in Circulation for Treatment of Atrial Fibrillation
Jan 4, 2008
|
13.6 KB
|
|
SAN DIEGO, Jan 04, 2008 /PRNewswire-FirstCall via COMTEX News Network/ -- CryoCor, Inc. (Nasdaq: CRYO), a medical device company focused on the treatment of cardiac arrhythmias, announced today the publication of a European study of atrial fibrillation patients treated with CryoCor's Cardiac Cryoablation System. The purpose of the study was to eval...
|
|
CryoCor Files Response to Patent Infringement Lawsuit
Dec 6, 2007
|
12.2 KB
|
|
SAN DIEGO, Dec 06, 2007 /PRNewswire-FirstCall via COMTEX News Network/ -- CryoCor, Inc. (Nasdaq: CRYO), a medical device company focused on the treatment of cardiac arrhythmias, announced today that it has filed a response to the recent patent infringement lawsuit brought against it by CryoCath Technologies Inc., and confirmed that it does not beli...
|
|
CryoCor to Present at Lazard Capital Markets Fourth Annual Healthcare Conference
Nov 20, 2007
|
11.8 KB
|
|
SAN DIEGO, Nov 20, 2007 /PRNewswire-FirstCall via COMTEX News Network/ -- CryoCor, Inc. (Nasdaq: CRYO), a medical device company focused on the treatment of cardiac arrhythmias, announced today that Edward F. Brennan, President and Chief Executive Officer, and Gregory J. Tibbitts, Chief Financial Officer, are scheduled to present at the Lazard Capi...
|
|
CryoCor Reports Third Quarter 2007 Results and Provides Commercial and Clinical Update
Nov 13, 2007
|
21.8 KB
|
|
SAN DIEGO, Nov 13, 2007 /PRNewswire-FirstCall via COMTEX News Network/ -- CryoCor, Inc. (Nasdaq: CRYO), a medical device company focused on the treatment of cardiac arrhythmias, today reported on its financial results for the quarter ended September 30, 2007 and provided an update on its commercial launch for the treatment of right atrial flutter, ...
|
|
CryoCor Announces Web cast and Conference Call of Third Quarter 2007 Results
Nov 7, 2007
|
12.3 KB
|
|
SAN DIEGO, Nov 07, 2007 /PRNewswire-FirstCall via COMTEX News Network/ -- CryoCor, Inc. (Nasdaq: CRYO), a medical device company focused on the treatment of cardiac arrhythmias, announced today that it will release its financial results for the quarter ended September 30, 2007 on Tuesday, November 13, 2007 after the close of the U.S. financial mark...
|
|
CryoCor Appoints New Vice President of Sales and Marketing
Nov 2, 2007
|
14.1 KB
|
|
SAN DIEGO, Nov 02, 2007 /PRNewswire-FirstCall via COMTEX News Network/ -- CryoCor, Inc. (Nasdaq: CRYO), a medical device company focused on the treatment of cardiac arrhythmias, announced today the appointment of Mark Adams as Vice President of Sales and Marketing. Mr. Adams brings to CryoCor over 20 years of cardiac related medical device sales an...
|
|
CryoCor to Present at CIBC World Markets 18th Annual Healthcare Conference
Oct 30, 2007
|
12.6 KB
|
|
SAN DIEGO, Oct 30, 2007 /PRNewswire-FirstCall via COMTEX News Network/ -- CryoCor, Inc. (Nasdaq: CRYO), a medical device company focused on the treatment of cardiac arrhythmias, announced today that Edward F. Brennan, President and Chief Executive Officer, and Gregory J. Tibbitts, Chief Financial Officer, are scheduled to present at the CIBC World ...
|
|
CryoCor Responds to Patent Infringement Lawsuit
Oct 17, 2007
|
12.0 KB
|
|
SAN DIEGO, Oct 17, 2007 /PRNewswire-FirstCall via COMTEX News Network/ -- CryoCor, Inc. (Nasdaq: CRYO), a medical device company focused on the treatment of cardiac arrhythmias, announced today that CryoCath Technologies Inc. has filed a lawsuit against CryoCor in the United States District Court for the District of Delaware alleging that CryoCor i...
|
|
|
Stock Information
CRYO - (NASD)
$1.35
+ 0.01
|
May 29, 2008
5:51 AM ET |
|
